Soru

Zorluk: OrtaOrdering Laboratory Tests

A 3939-year-old male presents to the internal medicine clinic for management of elevated blood pressure. He was diagnosed with hypertension six months ago and is currently prescribed maximal tolerated doses of amlodipine and benazepril. He reports consistent adherence to his medications. Over the past few weeks, he has experienced occasional muscle spasms in his lower extremities and mild generalized weakness. He does not take any over-the-counter medications, supplements, or illicit drugs. Blood pressure is 158/98158/98 mmHg, and heart rate is 7474/min. Physical examination reveals a normal body habitus with no abdominal bruits, striae, or abnormal fat distribution. Laboratory testing shows a serum potassium level of 3.13.1 mEq/L and a serum creatinine of 0.90.9 mg/dL. The patient has never been prescribed diuretic therapy. Based on the clinical presentation, which of the following diagnostic studies should be prioritized as the initial step to establish the underlying diagnosis?

  1. Plasma aldosterone concentration and plasma renin activityCevap
  2. B
    Computed tomography scan of the abdomen
  3. C
    Duplex ultrasonography of the renal arteries
  4. D
    24-hour urine fractionated metanephrines
  5. E
    Overnight low-dose dexamethasone suppression test

Cevap

The most appropriate initial diagnostic step is to measure plasma aldosterone concentration and plasma renin activity.
The correct answer identifies the need to screen for primary hyperaldosteronism in a young patient presenting with resistant hypertension and unprovoked hypokalemia. Measuring plasma aldosterone concentration alongside plasma renin activity is the most appropriate initial laboratory evaluation. Calculating the aldosterone-to-renin ratio (ARR) serves as the gold-standard screening test; an elevated aldosterone level with a suppressed renin level strongly suggests autonomous adrenal aldosterone production.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and basic laboratory values.
The patient has resistant hypertension (elevated despite two antihypertensives), unprovoked hypokalemia (3.13.1 mEq/L), and muscle spasms, without features of Cushing syndrome or pheochromocytoma.
Identifying the clinical triad of hypertension, spontaneous hypokalemia, and muscle weakness directs the differential toward primary hyperaldosteronism.
2
Determine the optimal screening modality for the suspected condition.
The gold standard initial biochemical screen for primary hyperaldosteronism is the aldosterone-to-renin ratio.
Biochemical evidence must be established to differentiate primary hyperaldosteronism (high aldosterone, low renin) from secondary hyperaldosteronism (high aldosterone, high renin) before any localization studies are performed.
3
Select the option that represents this biochemical screening.
Plasma aldosterone concentration and plasma renin activity is identified as the correct test.
This specific laboratory test provides the necessary values to calculate the diagnostic ratio and confirms the diagnosis before transitioning to imaging.

Anahtar Kavram

The initial diagnostic workup for suspected primary hyperaldosteronism in a patient with hypertension and hypokalemia requires measuring plasma aldosterone concentration and plasma renin activity.
Bu soruyu puanla